Minaris Advanced Therapies
Shiraz Ali is a seasoned professional with extensive experience in manufacturing operations within the biotechnology sector. Currently serving as the Director of Manufacturing Operations at Minaris Advanced Therapies since December 2019, Shiraz leads Cell and Gene Therapy operations and oversees a diverse team including associates, compliance investigators, and trainers. Previous roles include positions as Associate Director, Manager, and Associate Manager of Operations, showcasing a progressive career trajectory. Prior experience at Genentech from October 2012 to November 2019 involved various supervisory and technician roles in pharmaceutical manufacturing. Earlier in the career, Shiraz worked as a Manufacturing Technician at Aerotek. Shiraz holds a Bachelor of Science degree in Biochemistry from Santa Clara University, achieved in 2010.
This person is not in any teams
This person is not in any offices
Minaris Advanced Therapies
1 followers
Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider focused exclusively on cell and gene therapies. Minaris Advanced Therapies is headquartered in Philadelphia, Pennsylvania, and has more than 730,000 square feet of infrastructure across the United States, Europe and Asia. We have manufactured and released over 7,500 GMP batches and our global network supports therapy developers through early-stage development, clinical trials and commercial manufacturing. By combining scientific expertise with best-in-class manufacturing and testing services, we help bring safe, effective therapies to patients faster and more efficiently. With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. Minaris Advanced Therapies is wholly owned by Altaris, LLC.